Neogen Corp Files 8-K: Financial Statements & Exhibits
Ticker: NEOG · Form: 8-K · Filed: Dec 4, 2024 · CIK: 711377
| Field | Detail |
|---|---|
| Company | Neogen Corp (NEOG) |
| Form Type | 8-K |
| Filed Date | Dec 4, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.16 |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-statements, exhibits, disclosure
Related Tickers: NEOG
TL;DR
NEOG filed an 8-K with financial docs, nothing major to see here.
AI Summary
On December 4, 2024, Neogen Corporation filed an 8-K report. The filing primarily concerns financial statements and exhibits, indicating a routine disclosure of company information. No specific material events or transactions were detailed in the provided excerpt.
Why It Matters
This 8-K filing serves as a public record of Neogen Corporation's financial disclosures and exhibits, providing transparency to investors and stakeholders.
Risk Assessment
Risk Level: low — The filing appears to be a standard disclosure of financial statements and exhibits, not indicating any unusual or high-risk events.
Key Players & Entities
- Neogen Corporation (company) — Registrant
- December 04, 2024 (date) — Date of earliest event reported
- Michigan (location) — State of Incorporation
- 620 Lesher Place, Lansing, Michigan 48912 (address) — Principal Executive Offices
FAQ
What is the primary purpose of this 8-K filing for Neogen Corporation?
The primary purpose of this 8-K filing is to report financial statements and exhibits as of December 4, 2024.
What is Neogen Corporation's state of incorporation?
Neogen Corporation is incorporated in Michigan.
What is the address of Neogen Corporation's principal executive offices?
The address of Neogen Corporation's principal executive offices is 620 Lesher Place, Lansing, Michigan 48912.
What is the SEC file number for Neogen Corporation?
The SEC file number for Neogen Corporation is 000-17988.
What is the IRS Employer Identification Number for Neogen Corporation?
The IRS Employer Identification Number for Neogen Corporation is 38-2367843.
Filing Stats: 413 words · 2 min read · ~1 pages · Grade level 12 · Accepted 2024-12-04 07:59:04
Key Financial Figures
- $0.16 — nge on which registered Common Stock, $0.16 par value per share NEOG Nasdaq Glo
Filing Documents
- neog-20241204.htm (8-K) — 40KB
- neog-ex99_1.htm (EX-99.1) — 16KB
- neog-ex99_1s1.jpg (GRAPHIC) — 476KB
- neog-ex99_1s2.jpg (GRAPHIC) — 626KB
- neog-ex99_1s3.jpg (GRAPHIC) — 313KB
- neog-ex99_1s4.jpg (GRAPHIC) — 342KB
- neog-ex99_1s5.jpg (GRAPHIC) — 468KB
- neog-ex99_1s6.jpg (GRAPHIC) — 299KB
- neog-ex99_1s7.jpg (GRAPHIC) — 463KB
- neog-ex99_1s8.jpg (GRAPHIC) — 428KB
- neog-ex99_1s9.jpg (GRAPHIC) — 353KB
- neog-ex99_1s10.jpg (GRAPHIC) — 318KB
- neog-ex99_1s11.jpg (GRAPHIC) — 321KB
- neog-ex99_1s12.jpg (GRAPHIC) — 230KB
- neog-ex99_1s13.jpg (GRAPHIC) — 348KB
- 0000950170-24-133084.txt ( ) — 7039KB
- neog-20241204.xsd (EX-101.SCH) — 24KB
- neog-20241204_htm.xml (XML) — 5KB
01 Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure. On December 4, 2024 Neogen Corporation published presentation materials for the 2024 Piper Sandler Healthcare Conference, a copy of which is furnished as Exhibit 99.1 hereto and is incorporated herein by reference.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits 99.1 Investor Presentation dated December 4, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. NEOGEN CORPORATION Date: December 4, 2024 By: /s/ Amy M. Rocklin Name: Amy M. Rocklin Title: Chief Legal & Compliance Officer, Corporate Secretary